Statins and skeletal muscles toxicity: From clinical trials to everyday practice
The mechanism(s) underlying the occurrence of statin-induced myopathy are ill defined, but the results of observational studies and clinical trials provide compelling evidence that skeletal muscle toxicity is a frequent, dose-dependent, adverse event associated with all statins. It has been suggeste...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
Academic Press
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/56277 |